Preventing Alzheimer's disease (Q39549596)

13 September 2017

Preventing Alzheimer's disease (English)

1 reference

13 September 2017

0 references

1

Dennis J Selkoe

1 reference

PubMed ID

22997326

13 September 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

13 September 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

Science

1 reference

13 September 2017

337

1 reference

13 September 2017

6101

1 reference

13 September 2017

1488-1492

1 reference

National estimates of the prevalence of Alzheimer's disease in the United States.

13 September 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Alzheimer's disease: the challenge of the second century

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

The secretases: enzymes with therapeutic potential in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Testing the right target and right drug at the right stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

A beta oligomers - a decade of discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Alzheimer disease: multiple causes, multiple effects of apolipoprotein E4, and multiple therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Resolving controversies on the path to Alzheimer's therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

Leisure activities and the risk of amnestic mild cognitive impairment in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.1228541

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.1228541

1 reference

13 September 2017

1 reference

PubMed ID

22997326